 | • レポートコード：D0GIR-00562 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、細胞免疫療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。細胞免疫療法の種類別市場規模（自己細胞免疫療法、キメラ抗原受容体（CAR）T細胞療法、樹状細胞ベースのワクチン療法）、用途別市場規模（病院、クリニック、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Boehringer Ingelheim、Bristol-Myers Squibb、Gilead Sciences、Biogen、AbbVie、GSK、AstraZeneca、Amgen、Eli Lilly and Company、Apac Biotech、Green Cross Corp、Pfizer、Dendreon Pharmaceuticals (SanPower)、Bausch Health、Roche、JW CreaGene、Takara Bio ・地域別グローバル市場分析 2015年-2020年 ・細胞免疫療法の北米市場（アメリカ、カナダ、メキシコ） ・細胞免疫療法のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・細胞免疫療法のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・細胞免疫療法の南米市場（ブラジル、アルゼンチン） ・細胞免疫療法の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：自己細胞免疫療法、キメラ抗原受容体（CAR）T細胞療法、樹状細胞ベースのワクチン療法 ・用途別分析：病院、クリニック、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Cell-Based Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Cell-Based Immunotherapy sales will be xx in 2020 from Cell-Based Immunotherapy million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Cell-Based Immunotherapy market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Cell-Based Immunotherapy industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Cell-Based Immunotherapy and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Cell-Based Immunotherapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cell-Based Immunotherapy market has been segmented into:
Autologous Cellular Immunotherapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy
Dendritic Cell-based Vaccine Therapy
By Application, Cell-Based Immunotherapy has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cell-Based Immunotherapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Cell-Based Immunotherapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cell-Based Immunotherapy market.
The report offers in-depth assessment of the growth and other aspects of the Cell-Based Immunotherapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cell-Based Immunotherapy Market Share Analysis
Cell-Based Immunotherapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cell-Based Immunotherapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cell-Based Immunotherapy sales, revenue and market share for each player covered in this report.
The major players covered in Cell-Based Immunotherapy are:
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Gilead Sciences
Biogen
AbbVie
GSK
AstraZeneca
Amgen
Eli Lilly and Company
Apac Biotech
Green Cross Corp
Pfizer
Dendreon Pharmaceuticals (SanPower)
Bausch Health
Roche
JW CreaGene
Takara Bio
Among other players domestic and global, Cell-Based Immunotherapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Cell-Based Immunotherapy Market Overview
1.1 Product Overview and Scope of Cell-Based Immunotherapy
1.2 Classification of Cell-Based Immunotherapy by Therapy
1.2.1 Global Cell-Based Immunotherapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cell-Based Immunotherapy Revenue Market Share by Therapy in 2019
1.2.3 Autologous Cellular Immunotherapy
1.2.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy
1.2.5 Dendritic Cell-based Vaccine Therapy
1.3 Global Cell-Based Immunotherapy Market by End Users
1.3.1 Overview: Global Cell-Based Immunotherapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Cell-Based Immunotherapy Market by Regions
1.4.1 Global Cell-Based Immunotherapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cell-Based Immunotherapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cell-Based Immunotherapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cell-Based Immunotherapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell-Based Immunotherapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cell-Based Immunotherapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell-Based Immunotherapy Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Cell-Based Immunotherapy Industry Impact
1.5.1 COVID-19 Potential Implications for the Cell-Based Immunotherapy
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Cell-Based Immunotherapy
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Boehringer Ingelheim SWOT Analysis
2.2.4 Boehringer Ingelheim Product and Services
2.2.5 Boehringer Ingelheim Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Gilead Sciences SWOT Analysis
2.4.4 Gilead Sciences Product and Services
2.4.5 Gilead Sciences Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biogen
2.5.1 Biogen Details
2.5.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biogen SWOT Analysis
2.5.4 Biogen Product and Services
2.5.5 Biogen Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AbbVie SWOT Analysis
2.6.4 AbbVie Product and Services
2.6.5 AbbVie Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Amgen SWOT Analysis
2.9.4 Amgen Product and Services
2.9.5 Amgen Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eli Lilly and Company
2.10.1 Eli Lilly and Company Details
2.10.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Eli Lilly and Company SWOT Analysis
2.10.4 Eli Lilly and Company Product and Services
2.10.5 Eli Lilly and Company Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Apac Biotech
2.11.1 Apac Biotech Details
2.11.2 Apac Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Apac Biotech SWOT Analysis
2.11.4 Apac Biotech Product and Services
2.11.5 Apac Biotech Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Green Cross Corp
2.12.1 Green Cross Corp Details
2.12.2 Green Cross Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Green Cross Corp SWOT Analysis
2.12.4 Green Cross Corp Product and Services
2.12.5 Green Cross Corp Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Pfizer SWOT Analysis
2.13.4 Pfizer Product and Services
2.13.5 Pfizer Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Dendreon Pharmaceuticals (SanPower)
2.14.1 Dendreon Pharmaceuticals (SanPower) Details
2.14.2 Dendreon Pharmaceuticals (SanPower) Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Dendreon Pharmaceuticals (SanPower) SWOT Analysis
2.14.4 Dendreon Pharmaceuticals (SanPower) Product and Services
2.14.5 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.15 Bausch Health
2.15.1 Bausch Health Details
2.15.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Bausch Health SWOT Analysis
2.15.4 Bausch Health Product and Services
2.15.5 Bausch Health Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.16 Roche
2.16.1 Roche Details
2.16.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Roche SWOT Analysis
2.16.4 Roche Product and Services
2.16.5 Roche Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.17 JW CreaGene
2.17.1 JW CreaGene Details
2.17.2 JW CreaGene Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 JW CreaGene SWOT Analysis
2.17.4 JW CreaGene Product and Services
2.17.5 JW CreaGene Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.18 Takara Bio
2.18.1 Takara Bio Details
2.18.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Takara Bio SWOT Analysis
2.18.4 Takara Bio Product and Services
2.18.3 Takara Bio Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cell-Based Immunotherapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell-Based Immunotherapy Players Market Share
3.2.2 Top 10 Cell-Based Immunotherapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cell-Based Immunotherapy Revenue and Market Share by Regions
4.2 North America Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
4.3 Europe Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
4.5 South America Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
5 North America Cell-Based Immunotherapy Revenue by Countries
5.1 North America Cell-Based Immunotherapy Revenue by Countries (2015-2020)
5.2 USA Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
5.3 Canada Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
6 Europe Cell-Based Immunotherapy Revenue by Countries
6.1 Europe Cell-Based Immunotherapy Revenue by Countries (2015-2020)
6.2 Germany Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
6.3 UK Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
6.4 France Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
6.5 Russia Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
6.6 Italy Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cell-Based Immunotherapy Revenue by Countries
7.1 Asia-Pacific Cell-Based Immunotherapy Revenue by Countries (2015-2020)
7.2 China Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
7.3 Japan Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
7.4 Korea Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
7.5 India Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
8 South America Cell-Based Immunotherapy Revenue by Countries
8.1 South America Cell-Based Immunotherapy Revenue by Countries (2015-2020)
8.2 Brazil Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cell-Based Immunotherapy by Countries
9.1 Middle East & Africa Cell-Based Immunotherapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
9.3 UAE Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cell-Based Immunotherapy Revenue and Market Share by Therapy (2015-2020)
10.2 Global Cell-Based Immunotherapy Market Forecast by Therapy (2019-2024)
10.3 Autologous Cellular Immunotherapy Revenue Growth Rate (2015-2025)
10.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Growth Rate (2015-2025)
10.5 Dendritic Cell-based Vaccine Therapy Revenue Growth Rate (2015-2025)
11 Global Cell-Based Immunotherapy Market Segment by End Users
11.1 Global Cell-Based Immunotherapy Revenue Market Share by End Users (2015-2020)
11.2 Cell-Based Immunotherapy Market Forecast by End Users (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Cell-Based Immunotherapy Market Size Forecast (2021-2025)
12.1 Global Cell-Based Immunotherapy Market Size Forecast (2021-2025)
12.2 Global Cell-Based Immunotherapy Market Forecast by Regions (2021-2025)
12.3 North America Cell-Based Immunotherapy Revenue Market Forecast (2021-2025)
12.4 Europe Cell-Based Immunotherapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cell-Based Immunotherapy Revenue Market Forecast (2021-2025)
12.6 South America Cell-Based Immunotherapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cell-Based Immunotherapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cell-Based Immunotherapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cell-Based Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cell-Based Immunotherapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cell-Based Immunotherapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Cell-Based Immunotherapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Novartis Corporate Information, Location and Competitors
Table 7. Novartis Cell-Based Immunotherapy Major Business
Table 8. Novartis Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 9. Novartis SWOT Analysis
Table 10. Novartis Cell-Based Immunotherapy Product and Solutions
Table 11. Novartis Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 13. Boehringer Ingelheim Cell-Based Immunotherapy Major Business
Table 14. Boehringer Ingelheim Cell-Based Immunotherapy Total Revenue (USD Million) (2018-2019)
Table 15. Boehringer Ingelheim SWOT Analysis
Table 16. Boehringer Ingelheim Cell-Based Immunotherapy Product and Solutions
Table 17. Boehringer Ingelheim Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 19. Bristol-Myers Squibb Cell-Based Immunotherapy Major Business
Table 20. Bristol-Myers Squibb Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 21. Bristol-Myers Squibb SWOT Analysis
Table 22. Bristol-Myers Squibb Cell-Based Immunotherapy Product and Solutions
Table 23. Bristol-Myers Squibb Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Gilead Sciences Corporate Information, Location and Competitors
Table 25. Gilead Sciences Cell-Based Immunotherapy Major Business
Table 26. Gilead Sciences Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 27. Gilead Sciences SWOT Analysis
Table 28. Gilead Sciences Cell-Based Immunotherapy Product and Solutions
Table 29. Gilead Sciences Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Biogen Corporate Information, Location and Competitors
Table 31. Biogen Cell-Based Immunotherapy Major Business
Table 32. Biogen Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 33. Biogen SWOT Analysis
Table 34. Biogen Cell-Based Immunotherapy Product and Solutions
Table 35. Biogen Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. AbbVie Corporate Information, Location and Competitors
Table 37. AbbVie Cell-Based Immunotherapy Major Business
Table 38. AbbVie Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 39. AbbVie SWOT Analysis
Table 40. AbbVie Cell-Based Immunotherapy Product and Solutions
Table 41. AbbVie Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. GSK Corporate Information, Location and Competitors
Table 43. GSK Cell-Based Immunotherapy Major Business
Table 44. GSK Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 45. GSK SWOT Analysis
Table 46. GSK Cell-Based Immunotherapy Product and Solutions
Table 47. GSK Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. AstraZeneca Corporate Information, Location and Competitors
Table 49. AstraZeneca Cell-Based Immunotherapy Major Business
Table 50. AstraZeneca Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 51. AstraZeneca SWOT Analysis
Table 52. AstraZeneca Cell-Based Immunotherapy Product and Solutions
Table 53. AstraZeneca Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Amgen Corporate Information, Location and Competitors
Table 55. Amgen Cell-Based Immunotherapy Major Business
Table 56. Amgen Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 57. Amgen SWOT Analysis
Table 58. Amgen Cell-Based Immunotherapy Product and Solutions
Table 59. Amgen Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Eli Lilly and Company Corporate Information, Location and Competitors
Table 61. Eli Lilly and Company Cell-Based Immunotherapy Major Business
Table 62. Eli Lilly and Company Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 63. Eli Lilly and Company SWOT Analysis
Table 64. Eli Lilly and Company Cell-Based Immunotherapy Product and Solutions
Table 65. Eli Lilly and Company Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Apac Biotech Corporate Information, Location and Competitors
Table 67. Apac Biotech Cell-Based Immunotherapy Major Business
Table 68. Apac Biotech Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 69. Apac Biotech SWOT Analysis
Table 70. Apac Biotech Cell-Based Immunotherapy Product and Solutions
Table 71. Apac Biotech Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Green Cross Corp Corporate Information, Location and Competitors
Table 73. Green Cross Corp Cell-Based Immunotherapy Major Business
Table 74. Green Cross Corp Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 75. Green Cross Corp SWOT Analysis
Table 76. Green Cross Corp Cell-Based Immunotherapy Product and Solutions
Table 77. Green Cross Corp Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Pfizer Corporate Information, Location and Competitors
Table 79. Pfizer Cell-Based Immunotherapy Major Business
Table 80. Pfizer Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 81. Pfizer SWOT Analysis
Table 82. Pfizer Cell-Based Immunotherapy Product and Solutions
Table 83. Pfizer Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Dendreon Pharmaceuticals (SanPower) Corporate Information, Location and Competitors
Table 85. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Major Business
Table 86. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 87. Dendreon Pharmaceuticals (SanPower) SWOT Analysis
Table 88. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product and Solutions
Table 89. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Bausch Health Corporate Information, Location and Competitors
Table 91. Bausch Health Cell-Based Immunotherapy Major Business
Table 92. Bausch Health Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 93. Bausch Health SWOT Analysis
Table 94. Bausch Health Cell-Based Immunotherapy Product and Solutions
Table 95. Bausch Health Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Roche Corporate Information, Location and Competitors
Table 97. Roche Cell-Based Immunotherapy Major Business
Table 98. Roche Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 99. Roche SWOT Analysis
Table 100. Roche Cell-Based Immunotherapy Product and Solutions
Table 101. Roche Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. JW CreaGene Corporate Information, Location and Competitors
Table 103. JW CreaGene Cell-Based Immunotherapy Major Business
Table 104. JW CreaGene Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 105. JW CreaGene SWOT Analysis
Table 106. JW CreaGene Cell-Based Immunotherapy Product and Solutions
Table 107. JW CreaGene Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Takara Bio Cell-Based Immunotherapy Therapy and End Users
Table 109. Takara Bio Cell-Based Immunotherapy Major Business
Table 110. Takara Bio Cell-Based Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 111. Takara Bio SWOT Analysis
Table 112. Takara Bio Cell-Based Immunotherapy Product and Solutions
Table 113. Takara Bio Cell-Based Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Global Cell-Based Immunotherapy Revenue (Million USD) by Players (2015-2020)
Table 115. Global Cell-Based Immunotherapy Revenue Share by Players (2015-2020)
Table 116. Global Cell-Based Immunotherapy Revenue (Million USD) by Regions (2015-2020)
Table 117. Global Cell-Based Immunotherapy Revenue Market Share by Regions (2015-2020)
Table 118. North America Cell-Based Immunotherapy Revenue by Countries (2015-2020)
Table 119. North America Cell-Based Immunotherapy Revenue Market Share by Countries (2015-2020)
Table 120. Europe Cell-Based Immunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 121. Asia-Pacific Cell-Based Immunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 122. South America Cell-Based Immunotherapy Revenue by Countries (2015-2020)
Table 123. South America Cell-Based Immunotherapy Revenue Market Share by Countries (2015-2020)
Table 124. Middle East and Africa Cell-Based Immunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 125. Middle East and Africa Cell-Based Immunotherapy Revenue Market Share by Countries (2015-2020)
Table 126. Global Cell-Based Immunotherapy Revenue (Million USD) by Type (2015-2020)
Table 127. Global Cell-Based Immunotherapy Revenue Share by Type (2015-2020)
Table 128. Global Cell-Based Immunotherapy Revenue Forecast by Type (2021-2025)
Table 129. Global Cell-Based Immunotherapy Revenue by Application (2015-2020)
Table 130. Global Cell-Based Immunotherapy Revenue Share by Application (2015-2020)
Table 131. Global Cell-Based Immunotherapy Revenue Forecast by Application (2021-2025)
Table 132. Global Cell-Based Immunotherapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cell-Based Immunotherapy Picture
Figure 2. Global Cell-Based Immunotherapy Revenue Market Share by Therapy in 2019
Figure 3. Autologous Cellular Immunotherapy Picture
Figure 4. Chimeric Antigen Receptor (CAR) T-Cell Therapy Picture
Figure 5. Dendritic Cell-based Vaccine Therapy Picture
Figure 6. Cell-Based Immunotherapy Revenue Market Share by End Users in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Others Picture
Figure 11. Global Cell-Based Immunotherapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Cell-Based Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Cell-Based Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Cell-Based Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Cell-Based Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Cell-Based Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cell-Based Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Cell-Based Immunotherapy Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Cell-Based Immunotherapy Revenue Market Share in 2019
Figure 20. Global Top 10 Players Cell-Based Immunotherapy Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Cell-Based Immunotherapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Cell-Based Immunotherapy Revenue Market Share by Regions (2015-2020)
Figure 24. Global Cell-Based Immunotherapy Revenue Market Share by Regions in 2018
Figure 25. North America Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 26. Europe Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 28. South America Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 30. North America Cell-Based Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 31. North America Cell-Based Immunotherapy Revenue Market Share by Countries in 2019
Figure 32. USA Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 33. Canada Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 35. Europe Cell-Based Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Cell-Based Immunotherapy Revenue Market Share by Countries in 2019
Figure 37. Germany Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 38. UK Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 39. France Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 40. Russia Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 41. Italy Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Cell-Based Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Cell-Based Immunotherapy Revenue Market Share by Countries in 2019
Figure 44. China Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 45. Japan Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 46. Korea Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 47. India Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 49. South America Cell-Based Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 50. South America Cell-Based Immunotherapy Revenue Market Share by Countries in 2019
Figure 51. Brazil Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Cell-Based Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Cell-Based Immunotherapy Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 56. UAE Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Cell-Based Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 59. Global Cell-Based Immunotherapy Revenue Share by Type (2015-2020)
Figure 60. Global Cell-Based Immunotherapy Revenue Share by Type in 2019
Figure 61. Global Cell-Based Immunotherapy Market Share Forecast by Type (2021-2025)
Figure 62. Global Autologous Cellular Immunotherapy Revenue Growth Rate (2015-2020)
Figure 63. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Growth Rate (2015-2020)
Figure 64. Global Dendritic Cell-based Vaccine Therapy Revenue Growth Rate (2015-2020)
Figure 65. Global Cell-Based Immunotherapy Revenue Share by Application (2015-2020)
Figure 66. Global Cell-Based Immunotherapy Revenue Share by Application in 2019
Figure 67. Global Cell-Based Immunotherapy Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 69. Global Clinics Revenue Growth Rate (2015-2020)
Figure 70. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Cell-Based Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Cell-Based Immunotherapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Cell-Based Immunotherapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Cell-Based Immunotherapy Revenue Market Forecast (2021-2025)
Figure 76. Europe Cell-Based Immunotherapy Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Cell-Based Immunotherapy Revenue Market Forecast (2021-2025)
Figure 78. South America Cell-Based Immunotherapy Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Cell-Based Immunotherapy Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
腫瘍溶解性ウイルス免疫療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Oncolytic Virus Immunotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncolytic Virus…- がん免疫療法薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cancers Immunotherapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 細胞治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cell Theraputics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 皮膚B細胞リンパ腫治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cutaneous B-Cell Lymphoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- B細胞性非ホジキンリンパ腫（NHL）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…